2medicalnews on Nostr: In patients surviving #stroke, approximately 15% and 60% exhibit concurrent #diabetes ...
Published at
2024-06-28 07:31:58Event JSON
{
"id": "fb72e681c9e374a477f3c565bee082d3a96916ca8f7198579686cf10b03dfa95",
"pubkey": "eb139a9840b16dab967324d053f3bc39df8e58c3d53ce164ba04861c0f2f0ea0",
"created_at": 1719552718,
"kind": 1,
"tags": [
[
"t",
"stroke"
],
[
"t",
"diabetes"
],
[
"t",
"overweight"
]
],
"content": "In patients surviving #stroke, approximately 15% and 60% exhibit concurrent #diabetes mellitus and #overweight/obesity, respectively, necessitating heightened secondary prevention efforts. Despite glucagon-like peptide-1 receptor agonists (GLP-1 RAs) demonstrating improved outcomes for those with diabetes mellitus or obesity, their underutilization persists among eligible individuals\n\nhttp://2medical.news/2024/06/27/glucagon-like-peptide-1-receptor-agonists-and-stroke-a-systematic-review-and-meta-analysis-of-cardiovascular-outcome-trials",
"sig": "b01f475d84050d99b28fb3a1fbb2267ed5a630d4e1ee227ef0ed7a4e2e45681f6f713c9642ae65d89dcd44d0a1b3cd2668633fbcb1f07bd248f7c80040e3adb6"
}